<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230625058578N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-18</date_registration>
      <primary_sponsor>Artesh University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of suckable form of curcumin and ginger mouthwash on oral health and sense of taste</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of curcumin suck able form and ginger mouthwash on oral health and sense of taste in hemodialysis patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>99</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70915</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Randomization is a block randomization in blocks of six, which will be assigned to three intervention groups: ginger mouthwash, curcumin lozenge form, and control group. The randomization unit is individual. The randomization tool is web-based randomization. A block method with a volume of 6 is used to create a random allocation sequence. According to the total number of samples required for the study, which is 99 patients (two intervention groups A, B and control group C), a block of 6 including three groups A, B and C will be randomly designed through the software and then based on the sample size , 99 envelopes (33 envelopes containing paper containing A) and (33 envelopes containing paper containing B and (33 envelopes containing paper C) are prepared. Based on the list of six randomly prepared blocks, a trained person is responsible for allocating patients as It is random, after each patient is admitted to the ward, according to the block of six prepared in the first stage, each patient will be randomly placed in the intervention group (A and B) or the control group (C), and the sample process will be consecutive until the sample is completed. people will be assigned to the desired group in the order of their entry into the study and randomly through randomized blocks. The method of concealment is the use of Sequentially numbered, sealed opaque.</study_design>
      <phase>1-2</phase>
      <hc_freetext>oral hygiene.</hc_freetext>
      <i_freetext>Intervention 1: In the intervention group: in the ginger mouthwash group, patients use mouthwash in the morning and at night for 30 seconds to one minute inside the mouth according to the mouthwash instructions, i.e. 5-10 cc. Oral and dental hygiene, including dental floss, how to brush teeth, washing the mouth after every meal, teaching how to use mouthwash and suction form, were taught by the main researcher and the main researcher's associate nurse in the dialysis department, and all clients are asked to They should brush their teeth twice a day, the necessary supervision to do the work is done by the main researcher and through education to the families. None of the participants have dietary restrictions for this study and they continue to eat and maintain oral hygiene according to the routine of dialysis patients. The BOAS scale in each of these two groups is checked before the start of the study and after the completion of the study, after 1 month, and the patients' sense of taste is subjectively asked. Intervention 2: In the intervention group, the lozenges form of curcumin is used in the form of two in the morning and two in the evening. Oral and dental hygiene includes dental floss, how to brush your teeth, rinsing the mouth after every meal, training in the use of the lozenges form, by the researcher. The principal and the associate nurse of the principal researcher have been trained in the dialysis department and all patients are asked to brush their teeth twice a day. None of the participants have dietary restrictions for this study and they continue to eat and maintain oral hygiene according to the routine of dialysis patients. The BOAS scale in each of these two groups is checked before the start of the study and after the completion of the study, after 1 month, and the patients' sense of taste is subjectively asked. Intervention 3: Control group: In the control group, no medication is given and the routine care provided to the dialysis patients will continue. None of the participants have dietary restrictions for this study, and according to the routine of the dialysis patients, they continue with nutrition and oral hygiene. . The BOAS scale in each of these two groups is checked before the start of the study and after the completion of the study, after 1 month, and the patients' sense of taste is subjectively asked.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information about the effectiveness of the study includes the effect of the main outcome.

When:
The access period starts 6 months after the results are published

To whom:
Everyone can apply to receive

Conditions:
Any request is allowed.

Where to obtain:
Information is through email addresses and phone numbers. Mr. Alireza Hosseini 09123054946

How to obtain:
Send the request by phone or email and check the request by the author and then answer the request to the requester within 72 hours.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>foroozeh mehrabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>etemadzadeh street</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8784488447</zip>
        <telephone>+98 21 8609 6350</telephone>
        <email>f_mehrabi@ajaums.ac.ir</email>
        <affiliation>Artesh University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>fatemeh kalroozi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>kaj street</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8777601533</zip>
        <telephone>+98 21 7750 0909</telephone>
        <email>fkalroozi@yahoo.com</email>
        <affiliation>Artesh University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients over 18 years of age
Patients who They undergo dialysis three days a week and dialysis adequacy (Kt/V) is normal.
Mental and physical ability to use mouthwash and suction form
Being healthy and not having wounds or skin disease in the mouth and face area
Persons who have a score of more than 6 in the BIOS scale review</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Use of anti-inflammatory substances by hemodialysis patients in the past six weeks and at the time of examination
Antibiotic use
Having immune system deficiency
Suffering from blood platelet deficiency
Suffering from acute systemic diseases
Acute oral and dental infection
History of allergy to ginger and turmeric
Drug addiction
Suffering from mental and cognitive diseases that make it impossible to communicate with the patient
Medical problems such as history of radiotherapy, Sjogren's syndrome and the use of drugs that affect salivary glands and their secretion
Suffering from diabetes in those seeking help who take the inhaled form of curcumin
People whose sense of taste has been lost during another special disease (coronavirus patients, etc.)
Using mouthwash or artificial saliva</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In the intervention group: in the ginger mouthwash group, patients use mouthwash in the morning and at night for 30 seconds to one minute inside the mouth according to the mouthwash instructions, i.e. 5-10 cc. Oral and dental hygiene, including dental floss, how to brush teeth, washing the mouth after every meal, teaching how to use mouthwash and suction form, were taught by the main researcher and the main researcher's associate nurse in the dialysis department, and all clients are asked to They should brush their teeth twice a day, the necessary supervision to do the work is done by the main researcher and through education to the families. None of the participants have dietary restrictions for this study and they continue to eat and maintain oral hygiene according to the routine of dialysis patients. The BOAS scale in each of these two groups is checked before the start of the study and after the completion of the study, after 1 month, and the patients' sense of taste is subjectively asked.</i_keyword>
      <i_keyword>In the intervention group, the lozenges form of curcumin is used in the form of two in the morning and two in the evening. Oral and dental hygiene includes dental floss, how to brush your teeth, rinsing the mouth after every meal, training in the use of the lozenges form, by the researcher. The principal and the associate nurse of the principal researcher have been trained in the dialysis department and all patients are asked to brush their teeth twice a day. None of the participants have dietary restrictions for this study and they continue to eat and maintain oral hygiene according to the routine of dialysis patients. The BOAS scale in each of these two groups is checked before the start of the study and after the completion of the study, after 1 month, and the patients' sense of taste is subjectively asked.</i_keyword>
      <i_keyword>Control group: In the control group, no medication is given and the routine care provided to the dialysis patients will continue. None of the participants have dietary restrictions for this study, and according to the routine of the dialysis patients, they continue with nutrition and oral hygiene. . The BOAS scale in each of these two groups is checked before the start of the study and after the completion of the study, after 1 month, and the patients' sense of taste is subjectively asked.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Oral hygiene. Timepoint: before the intervention, immediately after the intervention and after 1 month after the end of the intervention. Method of measurement: Beck oral health assessment scale.</prim_outcome>
      <prim_outcome>Sense of taste. Timepoint: before the intervention, immediately after the intervention and after 1 month after the end of the intervention. Method of measurement: Subjective scale of sense of taste.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Artesh University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-06-19</approval_date>
        <contact_name>Ethics Committee of Tehran Army University of Medical Sciences</contact_name>
        <contact_address>Pirouzi St. - Abuzar Blvd. - North Rabzah St. - 22 Alley, No. 29, Unit 1 Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
